Monograph
C01EA01 - Alprostadil |
Not porphyrinogenic |
NP |
Rationale
Endogenous prostaglandin. No relevant CYP metabolism.
Chemical description
Prostaglandin E1.
Therapeutic characteristics
Alprostadil is used mainly in congenital heart disease and in erectile dysfunction.
Metabolism and pharmacokinetics
Metabolized in the lungs and excreted within 24 hours.
Preclinical data
None
Personal communication
None
Published experience
None
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
© NAPOS 2025